CI
LRCX icon

Clal Insurance’s Lam Research LRCX Stock Holding History

Clal Insurance’s Portfolio LRCX Stock Details LRCX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-5,400
Closed -$2.24M – 212
2025
Q1 		$2.24M Buy
+5,400
New +$425K 0.02% 84

Other funds holding LRCX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Clal Insurance's LRCX Position: Q1 2026 in Review

Clal Insurance reduced its Lam Research (LRCX) stake by 37% in Q1 2026, selling an estimated $45.4M and leaving 346,061 shares worth $74M. The position accounts for 0.45% of the portfolio, ranked #48.

Clal Insurance first reported a position in LRCX in Q4 2023 and has held it in 7 quarters since. The position peaked at $123M in Q3 2025. 2,632 funds tracked by Wall St. Rank hold LRCX as of Q1 2026.

  • Clal Insurance held 346,061 shares of Lam Research worth $74M as of Q1 2026.
  • Clal Insurance sold 202,939 Lam Research shares in Q1 2026, an estimated $45.4M.
  • Lam Research made up 0.45% of Clal Insurance's portfolio in Q1 2026, its #48 holding.
  • Clal Insurance first reported a position in Lam Research in Q4 2023 and has held it in 7 quarters since.
  • Clal Insurance's Lam Research position peaked at $123M in Q3 2025.
  • 2,632 funds tracked by Wall St. Rank held Lam Research as of Q1 2026.

Based on Clal Insurance's 13F filing for Q1 2026, filed 12 May 2026.